Rockwell Medical Inc.

NASDAQ: RMTI · Real-Time Price · USD
1.05
0.01 (0.48%)
At close: Aug 14, 2025, 3:59 PM
1.00
-4.76%
Pre-market: Aug 15, 2025, 06:48 AM EDT

Rockwell Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
101.49M 83.61M 72.81M 61.93M
Cost of Revenue
84M 74.91M 68.73M 64.35M
Gross Profit
17.48M 8.7M 4.08M -2.42M
Operating Income
608K -6.67M -16.78M -30.34M
Interest Income
92K 211K 33K 22K
Pretax Income
-480K -8.44M -18.68M -32.67M
Net Income
-480K -8.44M -18.68M -32.67M
Selling & General & Admin
16.86M 14.27M 17.74M 21.08M
Research & Development
19K 1.11M 3.12M 6.83M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
16.88M 15.37M 20.86M 27.92M
Interest Expense
1.25M 2.3M 1.94M 2.36M
Selling & Marketing Expenses
2.75M 2.13M 2.09M 5.73M
Cost & Expenses
100.88M 90.28M 89.59M 92.27M
Income Tax Expense
n/a n/a 1.9M 2.36M
Shares Outstanding (Basic)
31.06M 23.32M 9.87M 8.53M
Shares Outstanding (Diluted)
31.06M 23.32M 9.87M 8.53M
EPS (Basic)
-0.03 -0.36 -1.89 -3.83
EPS (Diluted)
-0.03 -0.36 -1.89 -3.83
EBITDA
2.95M -4.69M -16.17M -27.8M
EBIT
774K -6.14M -16.74M -30.31M
Depreciation & Amortization
2.18M 1.44M 576K 2.52M